• 15 June 2010
  • News
  • By

48-50-JK Agri Genetics Ltd-Strand Life Sciences-Suven Life Sciences Limited

JK Agri Genetics Ltd
President P S Dravid
Business Involved in R&D and marketing of agri biotech products (Bt cotton seeds)
Start-up Year 1989
Biotech Revenue Rs 35 crore
Address 1-10-177, 4th floor, Varun Towers, Begumpet, Hyderabad – 500016
Tel + 91-40-66316858
Fax +91-40-27764943
Website www.jkseeds.net

JK Agri Genetics Ltd.(JKAL), an erstwhile division of JK Tyre & Industries Ltd, clocked a total turnover of Rs 35 crores in 2009-2010. It was established in 1989 with its headquarters at Hyderabad, Andhra Pradesh. The company is concentrating on research and development, production, processing and marketing of hybrid seeds of sorghum, pearl millet, maize, cotton, rice, sunflower, tomato, okra and hot pepper. There are many hybrids marketed by the company. But fast moving hybrids are JK 99, JK DURGA, JK 666, JK INDRA, JK Varun (555), JK Chamundi. JK Agri Genetics got approval to launch its Bt cottonseeds in 2006 has sold 2.5 lakh packets. The company has been working on several genes for various traits like biotic and abiotic strains. It is also working on number of other crops for developing salinity/drought tolerant hybrids. It is building up its R&D as well as marker-assisted selection with novel traits with the help of biotechnology tools.

Strand Life Sciences

Chairman & Ceo Dr Vijay Chandru
Business Bioinformatics
Start-up Year -
Biotech Revenue Rs 35 crore
Address 5th Floor, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore-560024
Tel +91-80-40787263
Fax +91-80-40787299
Website www.strandls.com

Life science informatics company Strand Life Sciences has registered a total revenue of Rs 35 crore in the fiscal year ended March 31, 2010. Strand leverages its core strengths and intellectual property in data mining, predictive modeling, bioinformatics, and computational chemistry to develop products and solutions for drug discovery. Five of the top ten pharmaceutical companies, three of the top six biotechnology companies, and numerous academic institutions across the globe, are part of Strand’s customer profile. Leveraging its unmatched interdisciplinary scientific expertise with its decision enabling technologies, Strand empowers biomedical and research scientists gain deep insights from raw data. Strand offers products and services in the areas of omics-based technologies, drug discovery, predictive systems modeling and knowledge management.

Suven Life Sciences Limited
CEO Venkat Jasti
Business Drug discovery
Start-up Year 1989
Biotech Revenue Rs 33.5 crore
Address Serene Chambers, Road No. 5, Avenue - 7, Banjara Hills, Hyderabad-500 034, Andhra Pradesh
Tel +91- 40-23541142
Fax +91-40-2354-1152
Website  www.suven.com

Suven Life Sciences Limited, is a biopharmaceutical company specializing in drug discovery and developmental activities in Central Nervous System disorders. The revenues for the year ended Mar’ 2010 from drug discovery and R&D services stood at Rs 33.5 crore compared to Rs 21.03 crore for the corresponding previous year. Including CRAMS business, revenue stood at Rs 129.8 crore.

Suven’s major thrust on innovative R&D in Drug Discovery continues with a total spending of Rs 34.16 crore (26 per cent on revenue) for the year ended Mar’ 2010 which lead to growth in R&D costs by 16 percent.

During the quarter there were major qualitative achievements in granting a product patent from USA (US 7,649,097) and a product patent (EP 1919896) from European Union for Suven’s drug discovery pipeline which consists of 12 molecules on 6 targets in CNS arena which are at various stages of preclinical and clinical development and these patents are valid until 2025 in addition to the clinical candidate SUVN-502 for Alzheimer’s and Schizophrenia.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email